Cite
Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue.
MLA
Incecayir, Tuba, et al. “Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue.” Journal of Pharmaceutical Sciences, vol. 105, no. 2, Feb. 2016, pp. 925–34. EBSCOhost, https://doi.org/10.1016/j.xphs.2015.11.036.
APA
Incecayir, T., Jing Sun, Yasuhiro Tsume, Hao Xu, Tomoka Gose, Takeo Nakanishi, Ikumi Tamai, Hilfinger, J., Lipka, E., & Amidon, G. L. (2016). Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue. Journal of Pharmaceutical Sciences, 105(2), 925–934. https://doi.org/10.1016/j.xphs.2015.11.036
Chicago
Incecayir, Tuba, Jing Sun, Yasuhiro Tsume, Hao Xu, Tomoka Gose, Takeo Nakanishi, Ikumi Tamai, John Hilfinger, Elke Lipka, and Gordon L. Amidon. 2016. “Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir Analogue.” Journal of Pharmaceutical Sciences 105 (2): 925–34. doi:10.1016/j.xphs.2015.11.036.